| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Huffington Center on Aging and Departments of 2 Dermatology and 3 Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
Melanoma cells typically express wild-type p53, yet they are notoriously resistant to DNA-damaging agents. Here, we show that sodium butyrate (NaB), a histone deacetylase (HDAC) inhibitor, induced apoptosis in human melanoma cells in a dose- and time-dependent manner. Apoptosis was associated with HDAC1-dependent induction of Bax and acetylation of p53. Down-regulation of HDAC1 by an antisense vector sensitized the cells to NaB-induced apoptosis, whereas its overexpression conferred resistance to this agent. Increased HDAC1 levels and activity impaired NaB-mediated activation of Bax promoter and Bax protein levels. Finally, using p53-null melanoma cell line and RNA interference in cells expressing wild-type p53 protein, we show that Bax induction and NaB-mediated apoptosis is p53 dependent.
This article has been cited by other articles:
|
|
 |
|
  T. S. Cunneen, R. M. Conway, and M. C. Madigan In Vitro Effects of Histone Deacetylase Inhibitors and Mitomycin C on Tenon Capsule Fibroblasts and Conjunctival Melanoma Cells Arch Ophthalmol, April 1, 2009; 127(4): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zheng, F. Chu, P. M. Chou, C. Gallati, U. Dier, B. L. Mirkin, S. A. Mousa, and A. Rebbaa Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism Am J Physiol Cell Physiol, January 1, 2009; 296(1): C65 - C74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Fiskus, R. Rao, P. Fernandez, B. Herger, Y. Yang, J. Chen, R. Kolhe, A. Mandawat, Y. Wang, R. Joshi, et al. Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells Blood, October 1, 2008; 112(7): 2896 - 2905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-L. Wang, E. Salisbury, X. Shi, L. Timchenko, E. E. Medrano, and N. A. Timchenko HDAC1 Cooperates with C/EBP{alpha} in the Inhibition of Liver Proliferation in Old Mice J. Biol. Chem., September 19, 2008; 283(38): 26169 - 26178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-L. Wang, E. Salisbury, X. Shi, L. Timchenko, E. E. Medrano, and N. A. Timchenko HDAC1 Promotes Liver Proliferation in Young Mice via Interactions with C/EBP{beta} J. Biol. Chem., September 19, 2008; 283(38): 26179 - 26187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hayakawa, A. Abe, I. Kitabayashi, P. P. Pandolfi, and T. Naoe Acetylation of PML Is Involved in Histone Deacetylase Inhibitor-mediated Apoptosis J. Biol. Chem., September 5, 2008; 283(36): 24420 - 24425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. R. Fantin and V. M. Richon Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications Clin. Cancer Res., December 15, 2007; 13(24): 7237 - 7242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lee, J. H. Bae, M. J. Kim, H. S. Lee, M. K. Lee, B. S. Chung, D. W. Kim, C. D. Kang, and S. H. Kim Bcr-Abl-Independent Imatinib-Resistant K562 Cells Show Aberrant Protein Acetylation and Increased Sensitivity to Histone Deacetylase Inhibitors J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1084 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Keshelava, E. Davicioni, Z. Wan, L. Ji, R. Sposto, T. J. Triche, and C. P. Reynolds Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide J Natl Cancer Inst, July 18, 2007; 99(14): 1107 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Higashitsuji, H. Higashitsuji, T. Masuda, Y. Liu, K. Itoh, and J. Fujita Enhanced Deacetylation of p53 by the Anti-apoptotic Protein HSCO in Association with Histone Deacetylase 1 J. Biol. Chem., May 4, 2007; 282(18): 13716 - 13725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, S. Yin, Y. Meng, W. Sakr, and S. Sheng Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res., September 15, 2006; 66(18): 9323 - 9329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-S. Xu, G. Perez, L. Ngo, C.-Y. Gui, and P. A. Marks Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects Cancer Res., September 1, 2005; 65(17): 7832 - 7839. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
